The Gynaecological Cancer Research Centre, based at the University of Cape Town, focuses on programmes that address the current challenges facing patients with gynaecological cancers (the most common being cervical cancer).
The Centre also works with colleagues in East London to enhance its research capacity and support other SAMRC units in addressing the burden of disease.
Key focus areas
- Encourage teamwork among scientists and clinicians;
- Create a specialised biobank (collection of relevant research and data) and data-capturing system;
- Develop a registry (statistics source) that reflects the burden of disease;
- Establish the infrastructure and skills needed for real-time data-capturing (research nurses, for example);
- Prevent new and advanced cervical cancer cases by using point of care diagnostic tests and similar initiatives;
- Develop new and experimental vaccines for the Human Papilloma Virus (a group of viruses known as ‘HPV’ which increase a patient’s chance of developing cancer);
- Study therapeutic HPV vaccinations;
- Identify genetic markers linked to the progression and regression of gynaecological cancers;
- Monitor and evaluate HPV vaccination programmes;
- Establish effective ways to treat patients’ symptoms (pain relief) in regions with limited resources;
- Research the causes of late-onset cervical cancer;
- Promote the use of mobile technology for client follow-ups;
- Investigate the impact of HIV infection on recurring non-HPV related cancers; and
- Produce publications in relevant industry journals.
The five-year SAMRC grant for the Gynaecological Cancer Research Centre amounts to R2.5 million per year (excluding VAT), with a 5% increase each year depending on funding.
For more information, visit the Gynaecology Oncology Unit's Website
|Unit Director: Professor Lynette Denny